Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
A new diagnosis of type 1 diabetes (T1D) may be accompanied by numerous lifelong financial, emotional, and physical challenges, thus advancements in therapies that can delay the onset of clinical disease are crucial. T1D is an autoimmune condition involving destruction of pancreatic beta cells leadi...
Saved in:
Main Authors: | Alexander J. O’Donovan, Seth Gorelik, Laura M. Nally |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1477101/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
by: Alexander J. O’Donovan, et al.
Published: (2025-01-01) -
Circulating T Cell Subsets in Type 1 Diabetes
by: Aldo Ferreira-Hermosillo, et al.
Published: (2025-01-01) -
The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications
by: Monika Kamińska, et al.
Published: (2025-01-01) -
Insulinoma in Patients with Diabetes- A Systematic Review of Previously Reported Cases
by: Subhankar Chatterjee, et al.
Published: (2024-12-01) -
Clinical and Biochemical Features Used to Classify Type-1 and Type-2 Diabetes: A Scoping Review
by: Ulagamadesan Venkatesan, et al.
Published: (2024-04-01)